These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37195405)

  • 1. Cell penetrating peptides: Highlighting points in cancer therapy.
    Asrorov AM; Wang H; Zhang M; Wang Y; He Y; Sharipov M; Yili A; Huang Y
    Drug Dev Res; 2023 Sep; 84(6):1037-1071. PubMed ID: 37195405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic Cell-Penetrating Peptides as Efficient Intracellular Drug Delivery Tools.
    Park SE; Sajid MI; Parang K; Tiwari RK
    Mol Pharm; 2019 Sep; 16(9):3727-3743. PubMed ID: 31329448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rational design of cell-penetrating peptides for application in delivery systems.
    Kang Z; Ding G; Meng Z; Meng Q
    Peptides; 2019 Nov; 121():170149. PubMed ID: 31491454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane Crossing and Membranotropic Activity of Cell-Penetrating Peptides: Dangerous Liaisons?
    Walrant A; Cardon S; Burlina F; Sagan S
    Acc Chem Res; 2017 Dec; 50(12):2968-2975. PubMed ID: 29172443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches.
    Kardani K; Bolhassani A
    PLoS One; 2021; 16(2):e0247396. PubMed ID: 33606823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore.
    Trofimenko E; Grasso G; Heulot M; Chevalier N; Deriu MA; Dubuis G; Arribat Y; Serulla M; Michel S; Vantomme G; Ory F; Dam LC; Puyal J; Amati F; Lüthi A; Danani A; Widmann C
    Elife; 2021 Oct; 10():. PubMed ID: 34713805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-penetrating peptides: achievements and challenges in application for cancer treatment.
    Shin MC; Zhang J; Min KA; Lee K; Byun Y; David AE; He H; Yang VC
    J Biomed Mater Res A; 2014 Feb; 102(2):575-87. PubMed ID: 23852939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Current Role of Cell-Penetrating Peptides in Cancer Therapy.
    Feni L; Neundorf I
    Adv Exp Med Biol; 2017; 1030():279-295. PubMed ID: 29081059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New generation of cell-penetrating peptides: Functionality and potential clinical application.
    Reissmann S; Filatova MP
    J Pept Sci; 2021 May; 27(5):e3300. PubMed ID: 33615648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TargetCPP: accurate prediction of cell-penetrating peptides from optimized multi-scale features using gradient boost decision tree.
    Arif M; Ahmad S; Ali F; Fang G; Li M; Yu DJ
    J Comput Aided Mol Des; 2020 Aug; 34(8):841-856. PubMed ID: 32180124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Delivery Strategies to Improve the Target of Cell Penetrating Peptides Used for Tumor-Related Therapeutics.
    Zhang F; Yang D; Jiang S; Wu L; Qin L; He H; Zhang P
    Curr Pharm Des; 2018; 24(5):541-548. PubMed ID: 28758600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of amphipathic and cationic cyclic cell-penetrating peptides: Significant therapeutic delivery tool.
    Sajid MI; Moazzam M; Stueber R; Park SE; Cho Y; Malik NUA; Tiwari RK
    Peptides; 2021 Jul; 141():170542. PubMed ID: 33794283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
    Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
    Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taming Cell Penetrating Peptides: Never Too Old To Teach Old Dogs New Tricks.
    Zhang Q; Gao H; He Q
    Mol Pharm; 2015 Sep; 12(9):3105-18. PubMed ID: 26237247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-penetrating peptides in protein mimicry and cancer therapeutics.
    Zorko M; Jones S; Langel Ü
    Adv Drug Deliv Rev; 2022 Jan; 180():114044. PubMed ID: 34774552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cell-penetrating peptides involved in pathogenesis or applicable as drug delivery vectors.
    Hemmati S; Behzadipour Y; Haddad M
    Infect Genet Evol; 2020 Nov; 85():104474. PubMed ID: 32712315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-Penetrating Peptides: Design Strategies beyond Primary Structure and Amphipathicity.
    Kalafatovic D; Giralt E
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29117144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cell-penetrating peptides in potential anti-cancer therapy.
    Zhou M; Zou X; Cheng K; Zhong S; Su Y; Wu T; Tao Y; Cong L; Yan B; Jiang Y
    Clin Transl Med; 2022 May; 12(5):e822. PubMed ID: 35593206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Ala replacement with Aib in amphipathic cell-penetrating peptide on oligonucleotide delivery into cells.
    Wada S; Hashimoto Y; Kawai Y; Miyata K; Tsuda H; Nakagawa O; Urata H
    Bioorg Med Chem; 2013 Dec; 21(24):7669-73. PubMed ID: 24216093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.